Breaking News

BMS, DCRI in Clinical Data Access Alliance

June 24, 2014

Aims to support data sharing of clinical trial information for research

Bristol-Myers Squibb entered a collaboration with Duke University’s Clinical Research Institute (DCRI) to expand access to certain clinical trial information for independent scientific review through DCRI. This collaboration is one of a series of initiatives by BMS to support data sharing and disclosure of clinical trial information for scientific research and will include protocols, full clinical study reports (CSR) and de-identified patient-level data and study-level data for drugs and indications approved in the U.S. and/or Europe.
 
“Bristol-Myers Squibb’s collaboration with DCRI reflects our commitment to providing broader, more timely access to important clinical trial information and serves as a catalyst to strengthening public confidence in medicines, advancing science and improving public health,” said Francis Cuss, executive vice president and chief scientific officer, BMS.
 
“This program is a great leap forward for open science and is highly consistent with the DCRI’s mission to develop and share knowledge that improves the care of patients around the world through innovative clinical research,” said Dr. Eric Peterson, executive director of the DCRI.

Related Contract Manufacturing:

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research